April 18th, 2013
Advice for Physicians: How to Behave Online
Larry Husten, PHD
Although the internet represents “a new frontier in medicine” for physicians and patients, it also presents numerous and novel challenges to professionalism, according to a position paper from the American College of Physicians and the Federation of State Medical Boards published in the Annals of Internal Medicine.
The paper offers physicians a new conceptual “framework for analyzing medical ethics and professionalism issues” on the internet and provides recommendations for physicians on the use of email, blogs, social media sites, and more.
Although there are numerous valuable educational resources available, the authors advise physicians to evaluate the quality of online content before giving recommendations to their patients. Physicians who use blogs, Twitter, and other outlets to vent against patients are “disrespectful” and may “undermine trust in the profession.”
The paper also discusses the problem of confidentiality in the digital age and maintaining security on mobile devices.
The authors recommend that physicians maintain clear and distinct professional and social identities online, but professional standards must be maintained in both spheres. Patients should not be “friended” by physicians and should not be included in the personal or social online interactions of physicians. The authors also advise physicians and physicians-in-training that medical humor, though intended for fellow professionals, can easily find a wider audience on the internet.
Categories: General
Tags: American College of Physicians, online behavior, professionalism, social media
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Mineralocorticoid Receptor Antagonism — FINDing Another Benefit August 6, 2026Aldosterone plays a critical role in the homeostasis of blood pressure and volume by engaging mineralocorticoid receptors in the kidneys, heart, and other organs.1 However, overactivation of mineralocorticoid receptors contributes to the pathogenesis of chronic kidney disease (CKD) and heart failure, in part by causing inflammation and fibrosis....
- Cardiotoxic Effects and Microdystrophin Expression after Gene Therapy for DMD August 6, 2026In a patient with Duchenne muscular dystrophy, cardiotoxic effects developed after treatment with delandistrogene moxeparvovec. Microdystrophin levels in the heart and skeletal muscle were less than 1% of normal dystrophin levels.
- Obstructive Hypertrophic Cardiomyopathy August 6, 2026A 31-year-old man was evaluated for an abnormal ECG. Echocardiography revealed marked ventricular hypertrophy. Subsequent imaging (shown in a video) showed near-complete apposition of the ventricular walls during systole.
- Oxygen Targets after Cardiac Arrest — A LOGICAL Finding August 6, 2026In unresponsive patients after cardiac arrest, a complex pathophysiological response including potential brain injury, myocardial dysfunction, and systemic ischemia–reperfusion injury is at play, in addition to the challenges of the underlying cause of cardiac arrest.1 This complex and unique, but heterogeneous, constellation has prompted clinicians and researchers to...
- Sirolimus-Eluting Technology for the Treatment of Peripheral Artery Disease August 6, 2026Patients with advanced peripheral artery disease often undergo either surgical or endovascular revascularization for the treatment of lifestyle-limiting claudication or nonhealing lower-limb wounds. Major limitations of endovascular intervention include the high incidence of restenosis and the need for repeat intervention with standard balloon angioplasty. During the past decade, the use...
- Mineralocorticoid Receptor Antagonism — FINDing Another Benefit August 6, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
